CGTX
USDCognition Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.315
Hoch
$0.315
Tief
$0.306
Volumen
0.54M
Unternehmensfundamentaldaten
Marktkapitalisierung
19.7M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
1.07M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.